The impact of modified staining method on HER2 immunohistochemical staining for HER2-low breast cancer

被引：2
|
作者：
Chen, Yen-Yin [1 ,2 ,3 ,4 ]
Yang, Ching-Fe [3 ,4 ]
Hsu, Chih-Yi [3 ,4 ,5 ]
机构：
[1] Taipei Med Univ, Shuang Ho Hosp, Dept Pathol, Taipei, Taiwan
[2] Taipei Med Univ, Coll Med, Sch Med, Dept Pathol, Taipei, Taiwan
[3] Natl Yang Ming Chiao Tung Univ, Sch Med, Taipei, Taiwan
[4] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan
[5] Natl Taipei Univ Nursing & Hlth Sci, Coll Nursing, Taipei, Taiwan
来源：
PATHOLOGY | 2024年 / 56卷 / 01期
关键词：
EXPRESSION; FIXATION;
D O I：
10.1016/j.pathol.2023.06.002
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：122 / 124
页数：3
相关论文
共 50 条
  • [31] HER2 immunohistochemistry staining positivity is strongly predictive of tumor response to neoadjuvant chemotherapy in HER2 positive breast cancer
    Zhao, Jing
    Krishnamurti, Uma
    Zhang, Chao
    Meisel, Jane
    Wei, Zhimin
    Suo, Aili
    Aneja, Ritu
    Li, Zaibo
    Li, Xiaoxian
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (11)
  • [32] Breast carcinomas with borderline (2+) HER2 immunohistochemistry: percentage of cells with complete membrane staining for HER2 and the frequency of HER2 amplification
    Lee, Andrew H. S.
    Key, Heather P.
    Bell, Jane A.
    Hodi, Zsolt
    Ellis, Ian O.
    JOURNAL OF CLINICAL PATHOLOGY, 2011, 64 (06) : 490 - 492
  • [33] HER2-low breast cancer: evolution of HER2 expression from primary tumor to distant metastases
    Mengyuan Cai
    Ming Li
    Hong Lv
    Shuling Zhou
    Xiaoli Xu
    Ruohong Shui
    Wentao Yang
    BMC Cancer, 23
  • [34] HER2-Low Breast Cancer: Evolution of HER2 expression from Primary Tumor to Distant Metastases
    Cai, Mengyuan
    Li, Ming
    Lv, Hong
    Zhou, Shuling
    Xu, Xiaoli
    Shui, Ruohong
    Yang, Wentao
    LABORATORY INVESTIGATION, 2023, 103 (03) : S107 - S109
  • [35] A comprehensive appraisal of HER2 heterogeneity in HER2-amplified and HER2-low colorectal cancer
    Taiki Hashimoto
    Daisuke Takayanagi
    Junpei Yonemaru
    Tomoaki Naka
    Kengo Nagashima
    Erika Machida
    Takashi Kohno
    Yasushi Yatabe
    Yukihide Kanemitsu
    Ryuji Hamamoto
    Atsuo Takashima
    Kouya Shiraishi
    Shigeki Sekine
    British Journal of Cancer, 2023, 129 : 1176 - 1183
  • [36] The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status
    Nanae Horisawa
    Yayoi Adachi
    Daiki Takatsuka
    Kazuki Nozawa
    Yuka Endo
    Yuri Ozaki
    Kayoko Sugino
    Ayumi Kataoka
    Haruru Kotani
    Akiyo Yoshimura
    Masaya Hattori
    Masataka Sawaki
    Hiroji Iwata
    Breast Cancer, 2022, 29 : 234 - 241
  • [37] The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status
    Horisawa, Nanae
    Adachi, Yayoi
    Takatsuka, Daiki
    Nozawa, Kazuki
    Endo, Yuka
    Ozaki, Yuri
    Sugino, Kayoko
    Kataoka, Ayumi
    Kotani, Haruru
    Yoshimura, Akiyo
    Hattori, Masaya
    Sawaki, Masataka
    Iwata, Hiroji
    BREAST CANCER, 2022, 29 (02) : 234 - 241
  • [38] HER2-low breast cancer: evolution of HER2 expression from primary tumor to distant metastases
    Cai, Mengyuan
    Li, Ming
    Lv, Hong
    Zhou, Shuling
    Xu, Xiaoli
    Shui, Ruohong
    Yang, Wentao
    BMC CANCER, 2023, 23 (01)
  • [39] Challenges in the evaluation of HER2 and HER2-low in breast cancer in Brazil and recommendations of a multidisciplinary working group
    Gobbi, Helenice
    Carvalho, Filomena Marino
    De Brot, Marina
    Logullo, Angela Flavia
    Silva, Carlos Augusto Moreira
    Soares, Fernando Augusto
    Landeiro, Luciana
    Rahal, Rosemar
    Barrios, Carlos Henrique
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2024, 70 (10):
  • [40] A comprehensive appraisal of HER2 heterogeneity in HER2-amplified and HER2-low colorectal cancer
    Hashimoto, Taiki
    Takayanagi, Daisuke
    Yonemaru, Junpei
    Naka, Tomoaki
    Nagashima, Kengo
    Machida, Erika
    Kohno, Takashi
    Yatabe, Yasushi
    Kanemitsu, Yukihide
    Hamamoto, Ryuji
    Takashima, Atsuo
    Shiraishi, Kouya
    Sekine, Shigeki
    BRITISH JOURNAL OF CANCER, 2023, 129 (07) : 1176 - 1183
12345